A framework for the post-authorisation safety evaluation of vaccines in the EU
For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.
Project information
- EU PE&PV research network
- EUPAS1000000193
- EUPAS1000000233
- EUPAS1000000288
- Specific Contract 02 implementing Framework service contract EMA/2020/46/TDA/L5.06
Full title
A framework for the post-authorisation safety evaluation of vaccines in the EU (SAFETY-VAC)
Principal investigator
Dr. Carlos Durán, UMC Utrecht
Participating organisations
- Utrecht University, The Netherlands - consortium lead
- UMC Utrecht, The Netherlands - project co-lead
- VAC4EU, Belgium - project co-lead
- AEMPS, Spain
- FISABIO, Spain
- University of Verona, Italy
- VHIR, Spain
- Aarhus University, Denmark
- University of Eastern Finland, Finland
- Bordeaux PharmacoEpi, France
- ARS Toscana, Italy
- SoSeTe - Pedianet, Italy
- University of Oslo, Norway
- IDIAPJGol, Spain
- IACS, Spain
- Teamit Institute, Spain
- DSRU, UK
Status
Completed (2025)
Deliverables
Peer-reviewed scientific publications
- Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm. Riera-Arnau J, Luxi N, Riefolo F, Solorzano M, Pazos I, Ballarín E, Svingel LS, Chiusaroli L, Martín-Merino E, Barbieri E, Lopez-Lasanta M, Mohammadi S, Rotta D, Pacurariu A, Cohet C, Sturkenboom M, Durán CE; SAFETY‐VAC study consortium. Pharmacoepidemiol Drug Saf. 2026 Apr;35(4):e70362. doi: 10.1002/pds.70362. PMID: 41902365; PMCID: PMC13031886.